Metastatic, Non-small

Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/ Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/ 2/ 3 Gene fusion | DelveInsight

Veröffentlicht: 07.08.2025 um 18:07 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom California


+1(919)321-6187
www.delveinsight.com 

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/metastatic-non-small-cell-lung-cancer-market-forecast-analysis-and-with-focus-on-its-immunemolecular-biomarker-types-pd-l1-egfr-kras-alk-braf-met-ros-1-her2-ret-fusion-and-ntrk123-gene-fusion--delveinsight-301998962.html

en | boerse | 67943128 |